Our findings indicated for the first time that the NAMPT rs2058539 "CC" genotype is a marker of increased nonalcoholic fatty liver disease susceptibility; however, it needs to be supported by further investigations in other populations. The gene discussed is NAMPT; the disease is metabolic dysfunction-associated steatotic liver disease.